There is a new April 2020 ESMA consultation on the Transparency Regime for OTC derivatives. ESMA are proposing potentially wide-sweeping changes to post-trade transparency in their latest consultation. Deadline for responses is currently April 19th 2020. We encourage all market participants to respond to this vital consultation. We could finally witness the beginning of transparency … Continue reading MIFID II Transparency – Can we get it right this time?